![The Emerging Role of the Innate Immune Response in Idiosyncratic Drug Reactions | Pharmacological Reviews The Emerging Role of the Innate Immune Response in Idiosyncratic Drug Reactions | Pharmacological Reviews](https://pharmrev.aspetjournals.org/content/pharmrev/73/3/861/F1.large.jpg)
The Emerging Role of the Innate Immune Response in Idiosyncratic Drug Reactions | Pharmacological Reviews
![Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases](https://pub.mdpi-res.com/cancers/cancers-14-04385/article_deploy/html/images/cancers-14-04385-g002.png?1662701543)
Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases
![Diclofenac sodium loaded PLGA nanoparticles for inflammatory diseases with high anti-inflammatory properties at low dose: Formulation, characterization and in vivo HET-CAM analysis - ScienceDirect Diclofenac sodium loaded PLGA nanoparticles for inflammatory diseases with high anti-inflammatory properties at low dose: Formulation, characterization and in vivo HET-CAM analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0026286220300303-ga1.jpg)
Diclofenac sodium loaded PLGA nanoparticles for inflammatory diseases with high anti-inflammatory properties at low dose: Formulation, characterization and in vivo HET-CAM analysis - ScienceDirect
Synergistic Action of Diclofenac with Endotoxin-Mediated Inflammation Exacerbates Intestinal Injury in Vitro | ACS Infectious Diseases
![Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases](https://www.mdpi.com/cancers/cancers-14-04385/article_deploy/html/images/cancers-14-04385-g001.png)
Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases
![Naringin and Hesperidin Counteract Diclofenac-Induced Hepatotoxicity in Male Wistar Rats via Their Antioxidant, Anti-Inflammatory, and Antiapoptotic Activities Naringin and Hesperidin Counteract Diclofenac-Induced Hepatotoxicity in Male Wistar Rats via Their Antioxidant, Anti-Inflammatory, and Antiapoptotic Activities](https://static.hindawi.com/articles/omcl/volume-2021/9990091/figures/9990091.fig.006.jpg)
Naringin and Hesperidin Counteract Diclofenac-Induced Hepatotoxicity in Male Wistar Rats via Their Antioxidant, Anti-Inflammatory, and Antiapoptotic Activities
![Cancers | Free Full-Text | Diclofenac Enhances Docosahexaenoic Acid-Induced Apoptosis in Vitro in Lung Cancer Cells Cancers | Free Full-Text | Diclofenac Enhances Docosahexaenoic Acid-Induced Apoptosis in Vitro in Lung Cancer Cells](https://pub.mdpi-res.com/cancers/cancers-12-02683/article_deploy/html/images/cancers-12-02683-ag.png?1602082254)
Cancers | Free Full-Text | Diclofenac Enhances Docosahexaenoic Acid-Induced Apoptosis in Vitro in Lung Cancer Cells
![IJMS | Free Full-Text | Diclofenac Disrupts the Circadian Clock and through Complex Cross-Talks Aggravates Immune-Mediated Liver Injury—A Repeated Dose Study in Minipigs for 28 Days IJMS | Free Full-Text | Diclofenac Disrupts the Circadian Clock and through Complex Cross-Talks Aggravates Immune-Mediated Liver Injury—A Repeated Dose Study in Minipigs for 28 Days](https://pub.mdpi-res.com/ijms/ijms-24-01445/article_deploy/html/images/ijms-24-01445-g009.png?1674176314)
IJMS | Free Full-Text | Diclofenac Disrupts the Circadian Clock and through Complex Cross-Talks Aggravates Immune-Mediated Liver Injury—A Repeated Dose Study in Minipigs for 28 Days
![An adverse outcome pathway for immune-mediated and allergic hepatitis: a case study with the NSAID diclofenac | Archives of Toxicology An adverse outcome pathway for immune-mediated and allergic hepatitis: a case study with the NSAID diclofenac | Archives of Toxicology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00204-020-02767-6/MediaObjects/204_2020_2767_Fig1_HTML.png)
An adverse outcome pathway for immune-mediated and allergic hepatitis: a case study with the NSAID diclofenac | Archives of Toxicology
Diclofenac Sodium Triggers p53-Dependent Apoptosis in Human Corneal Epithelial Cells via ROS-Mediated Crosstalk | Chemical Research in Toxicology
![Frontiers | Topical Diclofenac Reprograms Metabolism and Immune Cell Infiltration in Actinic Keratosis Frontiers | Topical Diclofenac Reprograms Metabolism and Immune Cell Infiltration in Actinic Keratosis](https://www.frontiersin.org/files/Articles/455682/fonc-09-00605-HTML/image_m/fonc-09-00605-t001.jpg)
Frontiers | Topical Diclofenac Reprograms Metabolism and Immune Cell Infiltration in Actinic Keratosis
![Antioxidants | Free Full-Text | Diclofenac: A Nonsteroidal Anti-Inflammatory Drug Inducing Cancer Cell Death by Inhibiting Microtubule Polymerization and Autophagy Flux Antioxidants | Free Full-Text | Diclofenac: A Nonsteroidal Anti-Inflammatory Drug Inducing Cancer Cell Death by Inhibiting Microtubule Polymerization and Autophagy Flux](https://pub.mdpi-res.com/antioxidants/antioxidants-11-01009/article_deploy/html/images/antioxidants-11-01009-g007.png?1653046656)
Antioxidants | Free Full-Text | Diclofenac: A Nonsteroidal Anti-Inflammatory Drug Inducing Cancer Cell Death by Inhibiting Microtubule Polymerization and Autophagy Flux
![Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases](https://pub.mdpi-res.com/cancers/cancers-14-04385/article_deploy/html/images/cancers-14-04385-g003.png?1662701540)
Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases
![Antioxidants | Free Full-Text | Diclofenac Administration after Physical Training Blunts Adaptations of Peripheral Systems and Leads to Losses in Exercise Performance: In Vivo and In Silico Analyses Antioxidants | Free Full-Text | Diclofenac Administration after Physical Training Blunts Adaptations of Peripheral Systems and Leads to Losses in Exercise Performance: In Vivo and In Silico Analyses](https://pub.mdpi-res.com/antioxidants/antioxidants-10-01246/article_deploy/html/images/antioxidants-10-01246-ag.png?1628499492)
Antioxidants | Free Full-Text | Diclofenac Administration after Physical Training Blunts Adaptations of Peripheral Systems and Leads to Losses in Exercise Performance: In Vivo and In Silico Analyses
![Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery - British Journal of Anaesthesia Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery - British Journal of Anaesthesia](https://www.bjanaesthesia.org.uk/cms/attachment/2116996905/2085255530/gr1.jpg)
Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery - British Journal of Anaesthesia
![IJMS | Free Full-Text | Diclofenac Disrupts the Circadian Clock and through Complex Cross-Talks Aggravates Immune-Mediated Liver Injury—A Repeated Dose Study in Minipigs for 28 Days IJMS | Free Full-Text | Diclofenac Disrupts the Circadian Clock and through Complex Cross-Talks Aggravates Immune-Mediated Liver Injury—A Repeated Dose Study in Minipigs for 28 Days](https://pub.mdpi-res.com/ijms/ijms-24-01445/article_deploy/html/images/ijms-24-01445-g001.png?1674176339)
IJMS | Free Full-Text | Diclofenac Disrupts the Circadian Clock and through Complex Cross-Talks Aggravates Immune-Mediated Liver Injury—A Repeated Dose Study in Minipigs for 28 Days
![IJMS | Free Full-Text | Indomethacin and Diclofenac Hybrids with Oleanolic Acid Oximes Modulate Key Signaling Pathways in Pancreatic Cancer Cells IJMS | Free Full-Text | Indomethacin and Diclofenac Hybrids with Oleanolic Acid Oximes Modulate Key Signaling Pathways in Pancreatic Cancer Cells](https://pub.mdpi-res.com/ijms/ijms-23-01230/article_deploy/html/images/ijms-23-01230-ag.png?1643074893)
IJMS | Free Full-Text | Indomethacin and Diclofenac Hybrids with Oleanolic Acid Oximes Modulate Key Signaling Pathways in Pancreatic Cancer Cells
![Synergistic Action of Diclofenac with Endotoxin-Mediated Inflammation Exacerbates Intestinal Injury in Vitro | ACS Infectious Diseases Synergistic Action of Diclofenac with Endotoxin-Mediated Inflammation Exacerbates Intestinal Injury in Vitro | ACS Infectious Diseases](https://pubs.acs.org/cms/10.1021/acsinfecdis.0c00762/asset/images/medium/id0c00762_0001.gif)